Your browser doesn't support javascript.
loading
The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease.
Guo, Mei; Zhuang, Yanshuang; Wu, Yang; Zhang, Chun; Cheng, Xudong; Xu, Dong; Zhang, Zili.
Afiliação
  • Guo M; School of Nursing, Nanjing University of Chinese Medicine, Nanjing, China.
  • Zhuang Y; Taizhou Hospital of Traditional Chinese Medicine, Taizhou, China.
  • Wu Y; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang C; Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, China.
  • Cheng X; Suzhou TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Suzhou, China.
  • Xu D; Pancreas Center, the First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • Zhang Z; School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing, China.
Hepatol Commun ; 8(3)2024 03 01.
Article em En | MEDLINE | ID: mdl-38437058
ABSTRACT

BACKGROUND:

Dachshund homolog 1 (DACH1) is widely acknowledged for its involvement in regulating diverse cell fates, but its precise regulatory mechanism in ferroptosis remains elusive. In this study, we investigated whether DACH1 modulates ferroptosis through affecting P53/solute carrier family 25 member 37 (SLC25A37) signaling in hepatic fibrogenesis.

METHODS:

CRISPR-Cas9 system was used to knockout DACH1 in HSC to determine the effect of DACH1 on ferroptosis. Immunoprecipitation, pulldown, and mouse model of hepatic fibrogenesis were used to analyze the potential molecular mechanism of ferroptosis regulation by DACH1.

RESULTS:

We found that ferroptosis inducers increased the protein expression of DACH1 by suppressing the ubiquitin-proteasome signaling. DACH1 knockout can resist ferroptosis, whereas DACH1 knockin can enhance it. Interestingly, the upregulation of DACH1 resulted in the mitochondrial translocation of p53 by inducing phosphorylation at serine 392. The mutation of serine 392 can prevent the combination of DACH1 and p53, the mitochondrial translocation of p53, and DACH1-mediated ferroptosis. Moreover, SLC25A37 was identified as a candidate target for mitochondrial p53. The binding of p53 to SLC25A37 can enhance the iron uptake capacity of SLC25A37, which may cause an overload of iron in the mitochondria and hyperactive mitochondrial electron transport chain. Knockdown of SLC25A37 can impair p53-mediated mitochondrial iron overload and ferroptosis. Furthermore, treatment with erastin can induce HSC ferroptosis and relieve fibrotic lesion damage in the mouse model of hepatic fibrogenesis. HSC-specific knockdown of DACH1, p53, and SLC25A37 can abolish the induction of HSC ferroptosis and reversal of hepatic fibrogenesis by erastin treatment.

CONCLUSIONS:

Our findings suggest that the DACH1/P53/SLC25A37 signaling pathway is a promising target for fibrotic disorders and reveals new regulatory mechanisms of ferroptosis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Ferroptose Limite: Animals Idioma: En Revista: Hepatol Commun / Hepatol. commun / Hepatology communication Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteína Supressora de Tumor p53 / Ferroptose Limite: Animals Idioma: En Revista: Hepatol Commun / Hepatol. commun / Hepatology communication Ano de publicação: 2024 Tipo de documento: Article País de afiliação: China
...